Xometry (NASDAQ:XMTR) Director Sells $591,093.72 in Stock

Key Points

• Xometry Director Randolph Altschuler sold 5,721 shares at an average price of $103.32, generating $591,093.72. The sale covered tax withholding related to vested equity awards and reduced his ownership by 1.33% to 423,029 shares.
• Xometry shares traded at $102.53, near their 52-week high of $107.93, with a $5.31 billion market capitalization. The company recently exceeded quarterly earnings and revenue expectations, reporting 41.1% year-over-year revenue growth.
• Analysts maintain a generally positive view, with a “Moderate Buy” consensus and an average price target of $113.18; eight analysts rate the stock a Buy, while four rate it a Hold and one a Sell.

Xometry, Inc. (NASDAQ:XMTR - Get Free Report) Director Randolph Altschuler sold 5,721 shares of the stock in a transaction that occurred on Friday, October 2nd. The shares were sold at an average price of $103.32, for a total transaction of $591,093.72. Following the sale, the director directly owned 423,029 shares of the company's stock, valued at approximately $43,707,356.28. This trade represents a 1.33% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Randolph Altschuler also recently made the following trade(s):

• On Thursday, October 1st, Randolph Altschuler sold 10,000 shares of Xometry stock. The stock was sold at an average price of $104.04, for a total transaction of $1,040,400.00.
• On Tuesday, September 1st, Randolph Altschuler sold 10,000 shares of Xometry stock. The stock was sold at an average price of $90.82, for a total transaction of $908,200.00.

Xometry Price Performance

Shares of NASDAQ:XMTR traded down $1.70 during midday trading on Friday, reaching $102.53. 676,463 shares of the company were exchanged, compared to its average volume of 826,997. The stock has a market cap of $5.31 billion, a PE ratio of -170.88 and a beta of 1.23. The business's fifty day moving average is $92.03 and its two-hundred day moving average is $79.27. Xometry, Inc. has a one year low of $35.86 and a one year high of $107.93. The company has a current ratio of 3.21, a quick ratio of 3.20 and a debt-to-equity ratio of 0.41.

Xometry (NASDAQ:XMTR - Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.15 by $0.01. The company had revenue of $229.28 million for the quarter, compared to the consensus estimate of $215.22 million. Xometry had a negative net margin of 3.82% and a negative return on equity of 2.88%. Xometry's revenue for the quarter was up 41.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.09 EPS. As a group, analysts predict that Xometry, Inc. will post -0.01 earnings per share for the current year.

Hedge Funds Weigh In On Xometry

Institutional investors and hedge funds have recently made changes to their positions in the business. Integrated Wealth Concepts LLC bought a new stake in shares of Xometry in the 2nd quarter worth about $36,000. CoreCap Advisors LLC bought a new position in shares of Xometry in the 2nd quarter valued at about $97,000. Nykredit A S purchased a new position in Xometry in the second quarter worth about $103,000. PNC Financial Services Group Inc. grew its position in Xometry by 74.2% in the first quarter. PNC Financial Services Group Inc. now owns 1,636 shares of the company's stock worth $67,000 after acquiring an additional 697 shares in the last quarter. Finally, IPG Investment Advisors LLC purchased a new position in Xometry in the second quarter worth about $241,000. 97.31% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on XMTR shares. Raymond James Financial set a $120.00 target price on Xometry in a report on Tuesday, September 22nd. UBS Group increased their price target on Xometry from $88.00 to $95.00 and gave the company a "neutral" rating in a research note on Wednesday, August 5th. Rosenblatt Securities raised their price target on Xometry from $110.00 to $120.00 and gave the company a "buy" rating in a report on Tuesday, September 22nd. Citizens Jmp reaffirmed a "market outperform" rating and issued a $120.00 price objective on shares of Xometry in a research note on Monday, September 21st. Finally, JPMorgan Chase & Co. began coverage on Xometry in a report on Monday, August 24th. They set an "overweight" rating and a $120.00 price objective on the stock. Eight research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Xometry currently has an average rating of "Moderate Buy" and an average target price of $113.18.

About Xometry

Xometry, Inc is a digital manufacturing marketplace that connects businesses with a network of manufacturing suppliers. Its platform uses software and artificial intelligence to help customers obtain quotes, place orders, and manage production for custom parts and components.

The company supports a range of manufacturing processes, including computer numerical control machining, 3D printing, sheet metal fabrication, injection molding, and related services. Xometry serves customers across industries such as aerospace and defense, automotive, industrial machinery, consumer products, and healthcare.

Founded in 2013, Xometry has expanded its marketplace and digital manufacturing services internationally, serving customers and suppliers in North America, Europe, and Asia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.